Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2022 - IJCMAS--ICV 2022: 95.28 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020] For more details click here

Login as a Reviewer


See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 10, Issue:1, January, 2021

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com /
submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2021.10(1): 2616-2630
DOI: https://doi.org/10.20546/ijcmas.2021.1001.305


Therapeutic Uses of Fucoidan
Ramakrishnan1*, S. P. Preetha1, A. Arivuchelvan1,Parthiban2 and Thangapandiyan3
1Department of Veterinary Pharmacology and Toxicology, 2Department of Animal Biotechnology, 3Department of Veterinary Pathology, Madras Veterinary College,
Chennai, India
*Corresponding author
Abstract:

Fucoidan is a polysaccharide that primarily consists of groups of L-fucose and sulphate. As a result of its promising therapeutic results, Fucoidan is beneficial worldwide, especially in the food and pharmaceutical industries. The special biological structure is ascribed to its applaudable biological roles. Anti-oxidant, anti-tumor, anti-coagulant, anti-thrombotic, immunoregulatory, anti-viral, and anti-inflammatory effects are classic fucoidan-associated bioactivities. More recently, to further emphasise its therapeutic ability, a number of in vitro and in vivo experiments have been performed. This analysis reflects on the advances achieved in discovering the biological activities of fucoidan, which can be useful as a potential treatment. Therefore we have summarised the research performed in vitro and in vivo during the current decade. We expect this review and a variety of others can contribute as a theoretical basis for understanding and inspire further product development of fucoidan.


Keywords: Fucoidan, Galactofucan & Therapeutic benefits

Download this article as Download

How to cite this article:

Ramakrishnan, V., S. P. Preetha, A. Arivuchelvan, M. Parthiban and Thangapandiyan. 2021. Therapeutic Uses of Fucoidan.Int.J.Curr.Microbiol.App.Sci. 10(1): 2616-2630. doi: https://doi.org/10.20546/ijcmas.2021.1001.305
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

Citations